GlaxoSmithKline Australia
Administration route: 
Intramuscular injection
Vaccine group: 
Monovalent vaccines

Registered for use in people aged 2–15 years.

Each 0.5 mL monodose vial or pre-filled syringe contains:

  • 720 ELISA units of inactivated hepatitis A virus (HM175 strain)
  • 0.25 mg aluminium as aluminium hydroxide

Also contains traces of:

  • formaldehyde
  • neomycin
  • polysorbate 20

For full details, refer to the product information and consumer medicine information sheets for Havrix vaccine available on the TGA website.

Page history

Last updated: 
4 June 2018
Last reviewed: 
4 June 2018


enzyme-linked immunosorbent assay